Unknown

Dataset Information

Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients.


ABSTRACT:

Objectives

Macrophage activation syndrome (MAS) is a hyperinflammatory condition that is known to be secondary hemophagocytic lymphohistiocytosis (HLH) in patients with rheumatic disease. The aim of study was to evaluate the clinical manifestations and outcomes in patients with MAS with rheumatic disease.

Materials and methods

We performed a retrospective study of 20 adult patients who were diagnosed with MAS from 2012 to 2020. MAS was classified according to the HLH-2004 criteria. Patients' information, including clinical features, laboratory findings, and treatment regimens, was collected, and the overall survival rate was estimated by the Kaplan-Meier method.

Results

Twenty patients (18 women, 35.6 ± 18.3 years) who met the HLH-2004 criteria also fulfilled the 2016

SUBMITTER: Nam SH 

PROVIDER: S-EPMC9075640 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature